THIAMINE HYDROCHLORIDE, RIBOFLAVIN 5 PHOSPHATE SODIUM, DEXPANTHENOL AND NIACINAMIDE

THIAMINE HYDROCHLORIDE, RIBOFLAVIN 5 PHOSPHATE SODIUM, DEXPANTHENOL AND NIACINAMIDE was reported 30745 times

THIAMINE HYDROCHLORIDE, RIBOFLAVIN 5 PHOSPHATE SODIUM, DEXPANTHENOL AND NIACINAMIDE is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 GAIT SPASTIC 34 0.0991
1 ANTI-CYCLIC CITRULLINATED PEPTIDE ANTIBODY 44 0.0659
2 NEEDLE FATIGUE 30 0.0656
3 SERONEGATIVE ARTHRITIS 51 0.0445
4 LUPUS VULGARIS 54 0.0429
5 RELAPSING-REMITTING MULTIPLE SCLEROSIS 35 0.0405
6 DISLOCATION OF VERTEBRA 77 0.0337
7 C-REACTIVE PROTEIN 31 0.0334
8 ADJUSTMENT DISORDER WITH DEPRESSED MOOD 68 0.0328
9 DEEP VEIN THROMBOSIS POSTOPERATIVE 59 0.0295
10 RETINITIS 47 0.0272
11 X-RAY ABNORMAL 47 0.0263
12 LIGHT CHAIN ANALYSIS INCREASED 26 0.0252
13 FACET JOINT SYNDROME 77 0.0236
14 PERIPHERAL VENOUS DISEASE 89 0.0218
15 INFUSION SITE DISCHARGE 37 0.0211
16 ESSENTIAL HYPERTENSION 37 0.0202
17 SWOLLEN JOINT COUNT INCREASED 64 0.0201
18 MONOPARESIS 36 0.0199
19 HYPERTONIC BLADDER 55 0.0190
20 RHEUMATOID FACTOR POSITIVE 105 0.0182
21 BONE EROSION 64 0.0181
22 CATAPLEXY 25 0.0176
23 BLOOD PRESSURE SYSTOLIC ABNORMAL 42 0.0170
24 PRE-EXISTING CONDITION IMPROVED 105 0.0168
25 SPONDYLITIS 59 0.0162
26 RHEUMATIC FEVER 64 0.0143
27 EYELID PAIN 29 0.0143
28 C-REACTIVE PROTEIN ABNORMAL 88 0.0137
29 ANTI-CYCLIC CITRULLINATED PEPTIDE ANTIBODY POSITIVE 92 0.0128
30 INFUSION SITE HAEMORRHAGE 42 0.0128
31 GASTROINTESTINAL ULCER 28 0.0126
32 SPINAL FUSION SURGERY 50 0.0123
33 VITAMIN B12 DECREASED 35 0.0121
34 SEASONAL ALLERGY 171 0.0121
35 BLOOD PRESSURE DIASTOLIC ABNORMAL 30 0.0118
36 LIP DRY 104 0.0114
37 DUODENAL ULCER PERFORATION 84 0.0113
38 SKIN ABRASION 52 0.0110
39 WALKING AID USER 71 0.0108
40 MUSCLE INJURY 89 0.0107
41 MUSCLE SPASTICITY 131 0.0107
42 PNEUMONIA ASPIRATION 262 0.0105
43 NEPHROGENIC ANAEMIA 48 0.0104
44 SINUS PAIN 24 0.0103
45 NOCTURIA 122 0.0100
46 HYPERPARATHYROIDISM SECONDARY 25 0.0100
47 MEAN CELL VOLUME INCREASED 25 0.0097
48 SLEEP DISORDER DUE TO GENERAL MEDICAL CONDITION, INSOMNIA TYPE 63 0.0097
49 BURSITIS 114 0.0094
50 INFUSION SITE PRURITUS 29 0.0092
51 HELICOBACTER INFECTION 94 0.0091
52 PEMPHIGUS 114 0.0091
53 INFUSION SITE SWELLING 57 0.0090
54 MULTIPLE ALLERGIES 71 0.0090
55 PARANASAL SINUS DISCOMFORT 34 0.0090
56 GRIP STRENGTH DECREASED 79 0.0090
57 BLOOD CHLORIDE DECREASED 23 0.0089
58 HYPERCHOLESTEROLAEMIA 86 0.0089
59 FOOT DEFORMITY 98 0.0088
60 SLEEP APNOEA SYNDROME 168 0.0088
61 AUTOIMMUNE DISORDER 84 0.0086
62 ROSACEA 40 0.0086
63 BLOOD SODIUM INCREASED 23 0.0085
64 EXOSTOSIS 77 0.0084
65 DECREASED INTEREST 49 0.0083
66 DIABETIC FOOT 25 0.0082
67 SCIATICA 130 0.0081
68 HORDEOLUM 35 0.0081
69 MICTURITION URGENCY 92 0.0080
70 JOINT RANGE OF MOTION DECREASED 108 0.0080
71 INFUSION SITE REACTION 24 0.0080
72 FULL BLOOD COUNT DECREASED 161 0.0080
73 INCREASED TENDENCY TO BRUISE 73 0.0079
74 FOLLICULITIS 83 0.0079
75 DRUG TOLERANCE DECREASED 22 0.0078
76 FIBROMYALGIA 189 0.0078
77 HAND DEFORMITY 101 0.0077
78 PRODUCT ADMINISTRATION INTERRUPTED 60 0.0076
79 OBESITY 121 0.0076
80 WOUND INFECTION 82 0.0075
81 JOINT DISLOCATION 79 0.0075
82 INFUSION SITE ERYTHEMA 63 0.0075
83 WOUND COMPLICATION 25 0.0073
84 DERMATITIS CONTACT 83 0.0073
85 PERONEAL NERVE PALSY 41 0.0072
86 BREAST CANCER STAGE II 60 0.0072
87 BRAIN FOG 113 0.0072
88 GASTROOESOPHAGEAL REFLUX DISEASE 578 0.0072
89 UPPER-AIRWAY COUGH SYNDROME 59 0.0072
90 GLOSSODYNIA 160 0.0071
91 SNORING 27 0.0071
92 EAR PAIN 137 0.0070
93 LOWER LIMB FRACTURE 135 0.0070
94 RED CELL DISTRIBUTION WIDTH INCREASED 29 0.0070
95 ONYCHOCLASIS 48 0.0070
96 VITAMIN D DEFICIENCY 68 0.0070
97 BLADDER DISORDER 69 0.0069
98 HYPOPNOEA 24 0.0069
99 MENISCUS INJURY 42 0.0068
100 RED BLOOD CELL COUNT DECREASED 194 0.0068
101 INFUSION SITE PAIN 87 0.0067
102 BLOOD MAGNESIUM DECREASED 58 0.0067
103 HYPERACUSIS 25 0.0067
104 REHABILITATION THERAPY 26 0.0067
105 NEUROPATHY PERIPHERAL 635 0.0067
106 LUPUS-LIKE SYNDROME 60 0.0066
107 EXERCISE TOLERANCE DECREASED 38 0.0066
108 URINE ABNORMALITY 30 0.0066
109 PLANTAR FASCIITIS 22 0.0066
110 RHINITIS ALLERGIC 29 0.0065
111 RED BLOOD CELL SEDIMENTATION RATE INCREASED 72 0.0065
112 IRRITABLE BOWEL SYNDROME 139 0.0065
113 TENDON PAIN 49 0.0065
114 PULMONARY FIBROSIS 123 0.0064
115 NIGHT SWEATS 205 0.0064
116 BODY HEIGHT DECREASED 68 0.0064
117 HAEMOGLOBIN INCREASED 29 0.0064
118 SPINAL STENOSIS 26 0.0063
119 BACK DISORDER 102 0.0063
120 WOUND HAEMORRHAGE 23 0.0062
121 PERICARDITIS 104 0.0062
122 DIZZINESS POSTURAL 60 0.0062
123 INTERVERTEBRAL DISC DEGENERATION 57 0.0062
124 SYNOVITIS 111 0.0061
125 TRIGGER FINGER 25 0.0061
126 BODY TEMPERATURE DECREASED 60 0.0061
127 NEURALGIA 147 0.0060
128 SPINAL OSTEOARTHRITIS 53 0.0060
129 BALANCE DISORDER 520 0.0060
130 EAR INFECTION 160 0.0060
131 ANAL INCONTINENCE 54 0.0060
132 IRON DEFICIENCY 27 0.0060
133 TRIGEMINAL NEURALGIA 24 0.0060
134 WEIGHT FLUCTUATION 62 0.0059
135 POOR PERIPHERAL CIRCULATION 25 0.0059
136 LIGAMENT SPRAIN 58 0.0059
137 INCONTINENCE 62 0.0059
138 PRESCRIBED UNDERDOSE 117 0.0059
139 HEAD INJURY 184 0.0058
140 ATAXIA 69 0.0058
141 SINUSITIS 595 0.0058
142 SOMNAMBULISM 38 0.0058
143 GLOMERULAR FILTRATION RATE DECREASED 71 0.0058
144 PARANASAL SINUS HYPERSECRETION 22 0.0058
145 OSTEOARTHRITIS 244 0.0057
146 BLOOD PRESSURE FLUCTUATION 138 0.0057
147 TASTE DISORDER 116 0.0057
148 SINUS DISORDER 113 0.0057
149 HYPERVOLAEMIA 28 0.0057
150 GAIT INABILITY 189 0.0056
151 WHITE BLOOD CELL COUNT ABNORMAL 36 0.0056
152 SYNOVIAL CYST 26 0.0056
153 UPPER RESPIRATORY TRACT INFECTION 257 0.0056
154 HIATUS HERNIA 72 0.0056
155 SPINAL COLUMN STENOSIS 26 0.0055
156 SCOLIOSIS 34 0.0055
157 ONYCHOMADESIS 23 0.0055
158 SINUS CONGESTION 74 0.0055
159 PLATELET COUNT ABNORMAL 33 0.0055
160 LYMPHOCYTE COUNT DECREASED 96 0.0054
161 MUSCLE FATIGUE 23 0.0054
162 INSURANCE ISSUE 83 0.0054
163 HEAD DISCOMFORT 96 0.0054
164 PROTEIN URINE PRESENT 27 0.0054
165 INCORRECT DRUG ADMINISTRATION RATE 23 0.0054
166 BLOOD IRON DECREASED 64 0.0054
167 ROTATOR CUFF SYNDROME 69 0.0054
168 PLATELET COUNT INCREASED 70 0.0054
169 COMA 255 0.0053
170 POSTOPERATIVE WOUND INFECTION 36 0.0053
171 TOOTH INFECTION 70 0.0053
172 JOINT STIFFNESS 139 0.0053
173 CONCUSSION 41 0.0053
174 POOR QUALITY SLEEP 114 0.0053
175 BRONCHITIS 391 0.0053
176 EYE PAIN 297 0.0053
177 ABDOMINAL HERNIA 24 0.0053
178 TONGUE DISCOLOURATION 23 0.0053
179 WOUND 147 0.0053
180 IMPAIRED HEALING 172 0.0052
181 KNEE ARTHROPLASTY 110 0.0052
182 ON AND OFF PHENOMENON 29 0.0052
183 ORAL PAIN 116 0.0052
184 SKIN LACERATION 56 0.0051
185 HAEMATOCRIT DECREASED 102 0.0051
186 INFUSION SITE EXTRAVASATION 32 0.0051
187 TEMPERATURE INTOLERANCE 53 0.0051
188 NERVE INJURY 57 0.0051
189 MUSCLE TIGHTNESS 83 0.0051
190 STOMATITIS 309 0.0051
191 BOWEL MOVEMENT IRREGULARITY 39 0.0051
192 NYSTAGMUS 27 0.0051
193 MUSCLE STRAIN 44 0.0051
194 BLEPHAROSPASM 32 0.0051
195 TOOTH DISORDER 113 0.0051
196 HYPERKERATOSIS 28 0.0051
197 HOSPICE CARE 50 0.0051
198 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 243 0.0051
199 VIRAL UPPER RESPIRATORY TRACT INFECTION 24 0.0050
200 FOOD POISONING 27 0.0050
201 BENIGN PROSTATIC HYPERPLASIA 26 0.0050
202 NAIL DISORDER 44 0.0050
203 ULCER HAEMORRHAGE 34 0.0050
204 MELANOCYTIC NAEVUS 22 0.0050
205 APHONIA 70 0.0050
206 TUMOUR MARKER INCREASED 24 0.0050
207 ARTHROPOD BITE 37 0.0050
208 RESPIRATORY TRACT CONGESTION 79 0.0050
209 RASH VESICULAR 24 0.0050
210 HIP ARTHROPLASTY 76 0.0050
211 PERIPHERAL SWELLING 764 0.0050
212 MUSCULAR WEAKNESS 561 0.0049
213 BLOOD PRESSURE SYSTOLIC INCREASED 96 0.0049
214 CONTUSION 473 0.0049
215 VITAMIN D DECREASED 42 0.0049
216 GINGIVAL PAIN 39 0.0049
217 MUSCULOSKELETAL STIFFNESS 429 0.0049
218 RESTLESS LEGS SYNDROME 89 0.0049
219 BLOOD CHOLESTEROL INCREASED 227 0.0049
220 PERIPHERAL VASCULAR DISORDER 25 0.0048
221 LIMB DISCOMFORT 150 0.0048
222 GASTROINTESTINAL SOUNDS ABNORMAL 24 0.0048
223 PRODUCTIVE COUGH 231 0.0048
224 BRUXISM 26 0.0048
225 TENDERNESS 50 0.0048
226 THERMAL BURN 34 0.0048
227 MUSCULOSKELETAL PAIN 251 0.0048
228 CARPAL TUNNEL SYNDROME 67 0.0048
229 BACK INJURY 52 0.0048
230 JOINT INJURY 102 0.0048
231 POST-TRAUMATIC STRESS DISORDER 32 0.0048
232 DRY MOUTH 387 0.0048
233 URINE ODOUR ABNORMAL 28 0.0048
234 GAIT DISTURBANCE 911 0.0048
235 MUSCLE SPASMS 871 0.0047
236 ENERGY INCREASED 28 0.0047
237 BLOOD PRESSURE DIASTOLIC DECREASED 35 0.0047
238 OSTEOPOROSIS 195 0.0047
239 OCULAR DISCOMFORT 53 0.0047
240 LIMB INJURY 128 0.0047
241 NECK PAIN 263 0.0047
242 POLLAKIURIA 196 0.0047
243 ARTERIOSCLEROSIS CORONARY ARTERY 31 0.0047
244 FAECES SOFT 34 0.0047
245 COMPRESSION FRACTURE 25 0.0047
246 HOT FLUSH 351 0.0047
247 ANKLE FRACTURE 72 0.0046
248 HYPOAESTHESIA 696 0.0046
249 LIVER INJURY 114 0.0046
250 APHTHOUS ULCER 36 0.0046
251 URINARY TRACT INFECTION 788 0.0046
252 SLEEP DISORDER 325 0.0046
253 FLATULENCE 260 0.0046
254 EAR DISCOMFORT 47 0.0046
255 LIVER FUNCTION TEST INCREASED 98 0.0046
256 SCREAMING 29 0.0045
257 DECREASED ACTIVITY 49 0.0045
258 SYSTEMIC LUPUS ERYTHEMATOSUS 161 0.0045
259 PSORIATIC ARTHROPATHY 184 0.0045
260 DRY THROAT 46 0.0045
261 CENTRAL NERVOUS SYSTEM LESION 62 0.0045
262 MIGRAINE 430 0.0045
263 HYPERAESTHESIA 37 0.0045
264 RHINORRHOEA 291 0.0045
265 CANDIDA INFECTION 76 0.0045
266 CARDIAC FLUTTER 29 0.0045
267 BREAST MASS 30 0.0045
268 MULTIPLE SCLEROSIS RELAPSE 305 0.0044
269 FATIGUE 3459 0.0044
270 INTERVERTEBRAL DISC PROTRUSION 97 0.0044
271 PULMONARY MASS 66 0.0044
272 ARTHROPATHY 246 0.0044
273 DECUBITUS ULCER 36 0.0044
274 PHOTOPHOBIA 83 0.0044
275 ORAL HERPES 86 0.0044
276 NASOPHARYNGITIS 811 0.0044
277 BLOOD POTASSIUM DECREASED 132 0.0044
278 END STAGE RENAL DISEASE 80 0.0044
279 HEART RATE IRREGULAR 99 0.0044
280 VITREOUS FLOATERS 43 0.0044
281 PERIPHERAL COLDNESS 60 0.0044
282 URINARY INCONTINENCE 129 0.0043
283 OEDEMA 235 0.0043
284 MEMORY IMPAIRMENT 595 0.0043
285 DYSPEPSIA 426 0.0043
286 TOOTH ABSCESS 44 0.0043
287 SQUAMOUS CELL CARCINOMA OF SKIN 26 0.0043
288 FEELING JITTERY 82 0.0043
289 CYSTITIS 137 0.0043
290 MUSCULOSKELETAL DISCOMFORT 74 0.0043
291 PHARYNGEAL SWELLING 42 0.0043
292 HYPERSOMNIA 123 0.0043
293 AMNESIA 279 0.0043
294 DYSPNOEA EXERTIONAL 161 0.0043
295 SOMNOLENCE 857 0.0043
296 MAJOR DEPRESSION 31 0.0042
297 OXYGEN SATURATION DECREASED 238 0.0042
298 CONSTIPATION 922 0.0042
299 GLUCOSE TOLERANCE IMPAIRED 25 0.0042
300 DRY EYE 211 0.0042
301 SPINAL DISORDER 40 0.0042
302 BONE PAIN 247 0.0042
303 WHITE BLOOD CELL COUNT DECREASED 457 0.0042
304 MALABSORPTION 22 0.0042
305 GASTROENTERITIS VIRAL 76 0.0042
306 SINUS HEADACHE 25 0.0042
307 HEPATIC CIRRHOSIS 79 0.0042
308 DISCOMFORT 256 0.0042
309 FLUID RETENTION 213 0.0042
310 TINNITUS 192 0.0042
311 LOCALISED INFECTION 101 0.0042
312 PHARYNGITIS STREPTOCOCCAL 45 0.0042
313 INSOMNIA 1105 0.0041
314 ABDOMINAL DISCOMFORT 694 0.0041
315 ROAD TRAFFIC ACCIDENT 173 0.0041
316 AGEUSIA 103 0.0041
317 SKIN HAEMORRHAGE 61 0.0041
318 DYSSTASIA 120 0.0041
319 GROIN PAIN 36 0.0041
320 INITIAL INSOMNIA 42 0.0041
321 GASTROINTESTINAL PAIN 45 0.0041
322 OSTEOPENIA 62 0.0041
323 THERAPEUTIC RESPONSE UNEXPECTED 183 0.0041
324 APPETITE DISORDER 27 0.0041
325 DYSPHONIA 238 0.0041
326 SENSITIVE SKIN 30 0.0041
327 FULL BLOOD COUNT ABNORMAL 43 0.0041
328 SPINAL OPERATION 50 0.0041
329 SNEEZING 91 0.0041
330 TENDON RUPTURE 50 0.0040
331 ARTHRITIS 318 0.0040
332 EYE DISCHARGE 42 0.0040
333 RENAL CYST 32 0.0040
334 ORAL CANDIDIASIS 53 0.0040
335 IMMUNE SYSTEM DISORDER 53 0.0040
336 FOOD ALLERGY 31 0.0040
337 GASTROINTESTINAL INFECTION 36 0.0040
338 HEART RATE DECREASED 141 0.0040
339 SPINAL PAIN 47 0.0040
340 NERVE COMPRESSION 37 0.0040
341 IRON DEFICIENCY ANAEMIA 37 0.0040
342 WEIGHT DECREASED 1118 0.0040
343 PRODUCT USE COMPLAINT 63 0.0040
344 MOBILITY DECREASED 287 0.0040
345 COGNITIVE DISORDER 186 0.0040
346 PARAESTHESIA 626 0.0040
347 FRUSTRATION TOLERANCE DECREASED 32 0.0040
348 GASTROINTESTINAL INFLAMMATION 31 0.0040
349 FALL 1317 0.0040
350 FOOT FRACTURE 75 0.0040
351 MOVEMENT DISORDER 127 0.0040
352 INGUINAL HERNIA 24 0.0039
353 BLOOD POTASSIUM INCREASED 64 0.0039
354 MUSCULOSKELETAL CHEST PAIN 61 0.0039
355 LUNG DISORDER 193 0.0039
356 RIB FRACTURE 81 0.0039
357 MACULAR DEGENERATION 47 0.0039
358 FUNGAL INFECTION 131 0.0039
359 PETECHIAE 41 0.0039
360 SLUGGISHNESS 40 0.0039
361 WRIST FRACTURE 47 0.0039
362 JOINT EFFUSION 27 0.0039
363 BACTERIAL INFECTION 73 0.0039
364 ULCER 62 0.0039
365 PERIORBITAL SWELLING 22 0.0039
366 BACK PAIN 901 0.0039
367 BLOOD DISORDER 31 0.0039
368 OROPHARYNGEAL PAIN 358 0.0039
369 THERAPY CHANGE 38 0.0039
370 KNEE OPERATION 38 0.0039
371 DYSARTHRIA 145 0.0038
372 SENSORY LOSS 31 0.0038
373 INCORRECT ROUTE OF PRODUCT ADMINISTRATION 66 0.0038
374 NEUROLOGICAL SYMPTOM 22 0.0038
375 HYPOAESTHESIA ORAL 58 0.0038
376 SPINAL FRACTURE 77 0.0038
377 BLOOD UREA INCREASED 64 0.0038
378 MOUTH SWELLING 22 0.0038
379 FACIAL PAIN 34 0.0038
380 MIDDLE INSOMNIA 71 0.0038
381 DIVERTICULUM 27 0.0038
382 COORDINATION ABNORMAL 53 0.0038
383 DYSGRAPHIA 25 0.0038
384 CELLULITIS 191 0.0038
385 DEPRESSION 862 0.0038
386 VIRAL INFECTION 126 0.0038
387 ASTHENIA 1423 0.0038
388 THERAPY CESSATION 194 0.0038
389 HAEMOGLOBIN DECREASED 388 0.0038
390 SCAB 43 0.0038
391 DEVICE OCCLUSION 53 0.0038
392 THYROID DISORDER 58 0.0038
393 BLOOD COUNT ABNORMAL 57 0.0038
394 HAIR GROWTH ABNORMAL 26 0.0038
395 MULTIPLE SCLEROSIS 179 0.0037
396 PARAESTHESIA ORAL 54 0.0037
397 PAIN IN JAW 106 0.0037
398 DECREASED APPETITE 869 0.0037
399 GOUT 67 0.0037
400 DELUSION 58 0.0037
401 PAIN IN EXTREMITY 1100 0.0037
402 ATRIAL FIBRILLATION 363 0.0037
403 EYE INFECTION 42 0.0037
404 BASAL CELL CARCINOMA 58 0.0037
405 BLOOD PRESSURE INCREASED 568 0.0037
406 CHRONIC KIDNEY DISEASE 282 0.0037
407 CLOSTRIDIUM DIFFICILE INFECTION 81 0.0037
408 MUSCLE ATROPHY 47 0.0037
409 BLISTER 208 0.0037
410 INFLAMMATION 191 0.0037
411 IMPAIRED DRIVING ABILITY 42 0.0037
412 LOWER RESPIRATORY TRACT INFECTION 168 0.0037
413 POST PROCEDURAL INFECTION 30 0.0037
414 HYPERLIPIDAEMIA 44 0.0037
415 RESPIRATORY DISORDER 110 0.0037
416 NASAL CONGESTION 216 0.0037
417 LACRIMATION INCREASED 111 0.0037
418 KIDNEY INFECTION 72 0.0037
419 INFUSION RELATED REACTION 243 0.0037
420 HYPOKINESIA 53 0.0036
421 RESPIRATORY TRACT INFECTION 95 0.0036
422 NEPHROLITHIASIS 167 0.0036
423 HYPOPHAGIA 93 0.0036
424 PRODUCT FORMULATION ISSUE 24 0.0036
425 JOINT SWELLING 439 0.0036
426 FEELING DRUNK 27 0.0036
427 PRODUCT SUBSTITUTION ISSUE 209 0.0036
428 FLANK PAIN 34 0.0036
429 LABORATORY TEST ABNORMAL 107 0.0036
430 COUGH 1016 0.0036
431 BONE DISORDER 66 0.0036
432 PRESCRIBED OVERDOSE 70 0.0036
433 TENDONITIS 56 0.0036
434 DENTAL CARIES 40 0.0036
435 DERMATITIS ACNEIFORM 22 0.0036
436 ARTHRALGIA 1503 0.0036
437 PLASMA CELL MYELOMA 141 0.0036
438 ANXIETY 1027 0.0036
439 FOREIGN BODY SENSATION IN EYES 23 0.0036
440 ORAL DISCOMFORT 50 0.0036
441 TYPE 2 DIABETES MELLITUS 121 0.0036
442 MUSCLE DISORDER 29 0.0036
443 BODY TEMPERATURE INCREASED 73 0.0036
444 HALLUCINATION 269 0.0036
445 HERNIA 69 0.0036
446 SKIN INFECTION 40 0.0036
447 VENTRICULAR EXTRASYSTOLES 37 0.0036
448 ALOPECIA 697 0.0035
449 HEPATIC STEATOSIS 66 0.0035
450 ABNORMAL FAECES 29 0.0035
451 GASTROINTESTINAL DISORDER 316 0.0035
452 NODULE 46 0.0035
453 HERPES ZOSTER 202 0.0035
454 CHILLS 412 0.0035
455 DIARRHOEA 2267 0.0035
456 NASAL DRYNESS 22 0.0035
457 FEEDING DISORDER 71 0.0035
458 RHEUMATOID ARTHRITIS 397 0.0035
459 SENSORY DISTURBANCE 56 0.0035
460 ABDOMINAL DISTENSION 364 0.0035
461 DELIRIUM 121 0.0035
462 HYPERCALCAEMIA 43 0.0035
463 BLOOD THYROID STIMULATING HORMONE INCREASED 32 0.0035
464 LYMPHOEDEMA 24 0.0035
465 MUSCLE TWITCHING 80 0.0035
466 HEADACHE 2175 0.0035
467 MUSCULOSKELETAL DISORDER 66 0.0035
468 PELVIC FRACTURE 27 0.0035
469 INFLUENZA 385 0.0034
470 BLOOD SODIUM DECREASED 65 0.0034
471 SUPRAVENTRICULAR TACHYCARDIA 33 0.0034
472 DIZZINESS 1719 0.0034
473 HAIR TEXTURE ABNORMAL 46 0.0034
474 HEPATIC ENZYME INCREASED 234 0.0034
475 WEIGHT INCREASED 767 0.0034
476 BEDRIDDEN 45 0.0034
477 BLOOD PRESSURE ABNORMAL 68 0.0034
478 NEUTROPHIL COUNT INCREASED 35 0.0034
479 SKIN DISCOLOURATION 157 0.0034
480 HICCUPS 28 0.0034
481 ORAL DISORDER 25 0.0034
482 SARS-COV-2 TEST POSITIVE 45 0.0034
483 SQUAMOUS CELL CARCINOMA 32 0.0034
484 ATRIAL FLUTTER 27 0.0034
485 HAEMORRHOIDS 66 0.0034
486 POOR VENOUS ACCESS 35 0.0034
487 EATING DISORDER 72 0.0034
488 ACUTE RESPIRATORY FAILURE 65 0.0034
489 RETCHING 72 0.0034
490 SWELLING 316 0.0034
491 PANIC ATTACK 123 0.0034
492 EYE HAEMORRHAGE 45 0.0034
493 UROSEPSIS 31 0.0034
494 IMMUNODEFICIENCY 50 0.0034
495 QUALITY OF LIFE DECREASED 45 0.0034
496 SUNBURN 25 0.0033
497 COVID-19 587 0.0033
498 BLOOD TEST ABNORMAL 47 0.0033
499 PRODUCT DISTRIBUTION ISSUE 31 0.0033
500 MYALGIA 567 0.0033
501 FEELING ABNORMAL 797 0.0033
502 FLUSHING 338 0.0033
503 URINE OUTPUT DECREASED 29 0.0033
504 BLOOD PRESSURE DECREASED 220 0.0033
505 ILLNESS 341 0.0033
506 BLOOD CALCIUM INCREASED 29 0.0033
507 FEELING COLD 92 0.0033
508 IMPAIRED GASTRIC EMPTYING 45 0.0033
509 THROAT IRRITATION 148 0.0033
510 FURUNCLE 26 0.0033
511 DYSKINESIA 133 0.0033
512 CONTRAINDICATED PRODUCT ADMINISTERED 99 0.0033
513 MITRAL VALVE INCOMPETENCE 37 0.0033
514 PNEUMONIA BACTERIAL 30 0.0033
515 PRODUCT DOSE OMISSION IN ERROR 92 0.0032
516 EYE PRURITUS 109 0.0032
517 ABDOMINAL PAIN UPPER 666 0.0032
518 VISION BLURRED 444 0.0032
519 HYSTERECTOMY 28 0.0032
520 IMPAIRED WORK ABILITY 69 0.0032
521 LIVE BIRTH 27 0.0032
522 CATARACT 192 0.0032
523 CONFUSIONAL STATE 521 0.0032
524 FREQUENT BOWEL MOVEMENTS 87 0.0032
525 RESPIRATORY SYNCYTIAL VIRUS INFECTION 28 0.0032
526 DIVERTICULITIS 89 0.0032
527 HEART RATE INCREASED 318 0.0032
528 SKIN LESION 88 0.0032
529 GENERAL SYMPTOM 24 0.0032
530 IMPAIRED QUALITY OF LIFE 46 0.0032
531 FEMUR FRACTURE 99 0.0032
532 LACERATION 30 0.0032
533 PULMONARY CONGESTION 42 0.0032
534 PLATELET COUNT DECREASED 339 0.0032
535 BURNING SENSATION 223 0.0032
536 SKIN FISSURES 62 0.0032
537 PALPITATIONS 370 0.0032
538 DIPLOPIA 82 0.0032
539 RENAL DISORDER 147 0.0032
540 HYPERTENSION 668 0.0032
541 CHOLECYSTECTOMY 36 0.0031
542 INTERNAL HAEMORRHAGE 36 0.0031
543 THERAPEUTIC PRODUCT EFFECT DECREASED 141 0.0031
544 SPINAL COMPRESSION FRACTURE 26 0.0031
545 CHEST DISCOMFORT 322 0.0031
546 INFECTION 455 0.0031
547 CYST 39 0.0031
548 GALLBLADDER DISORDER 56 0.0031
549 ANGER 106 0.0031
550 EPISTAXIS 234 0.0031
551 WHITE BLOOD CELL COUNT INCREASED 120 0.0031
552 CARDIAC MURMUR 27 0.0031
553 WHEEZING 185 0.0031
554 LETHARGY 179 0.0031
555 HIP FRACTURE 100 0.0031
556 TREMOR 516 0.0031
557 UNEVALUABLE EVENT 235 0.0031
558 ATELECTASIS 30 0.0031
559 DEPRESSED MOOD 164 0.0031
560 CARDIOMEGALY 38 0.0031
561 HUNGER 43 0.0031
562 TOOTH FRACTURE 34 0.0031
563 DYSURIA 113 0.0031
564 IMMUNOSUPPRESSION 27 0.0031
565 ELECTROCARDIOGRAM ABNORMAL 24 0.0031
566 AFFECTIVE DISORDER 24 0.0030
567 OEDEMA PERIPHERAL 372 0.0030
568 TOOTHACHE 55 0.0030
569 DEHYDRATION 405 0.0030
570 HALLUCINATION, VISUAL 64 0.0030
571 NERVOUSNESS 158 0.0030
572 BLOOD CALCIUM DECREASED 34 0.0030
573 THIRST 54 0.0030
574 RENAL PAIN 32 0.0030
575 EYE IRRITATION 173 0.0030
576 OVARIAN CYST 30 0.0030
577 HEPATIC ENCEPHALOPATHY 28 0.0030
578 PNEUMONIA 971 0.0030
579 NEPHROPATHY 28 0.0030
580 CHOLELITHIASIS 98 0.0030
581 FEELING HOT 183 0.0030
582 THROMBOSIS 240 0.0030
583 INTENTIONAL PRODUCT USE ISSUE 261 0.0030
584 PAIN 1829 0.0030
585 CEREBRAL DISORDER 22 0.0030
586 VERTIGO 180 0.0030
587 THINKING ABNORMAL 55 0.0029
588 ERUCTATION 57 0.0029
589 SKIN ULCER 76 0.0029
590 VISUAL IMPAIRMENT 364 0.0029
591 POLYURIA 24 0.0029
592 EYE SWELLING 109 0.0029
593 CHEST PAIN 541 0.0029
594 EYE DISORDER 96 0.0029
595 DYSPHAGIA 276 0.0029
596 NAUSEA 2299 0.0029
597 BLOOD ALBUMIN DECREASED 23 0.0029
598 MYOSITIS 26 0.0029
599 HEREDITARY ANGIOEDEMA 31 0.0029
600 SLEEP DISORDER DUE TO A GENERAL MEDICAL CONDITION 49 0.0029
601 ADRENAL INSUFFICIENCY 35 0.0029
602 COVID-19 PNEUMONIA 34 0.0029
603 SKIN CANCER 62 0.0029
604 PRESYNCOPE 70 0.0029
605 OROPHARYNGEAL DISCOMFORT 26 0.0029
606 INTENTIONAL DOSE OMISSION 82 0.0029
607 SECRETION DISCHARGE 36 0.0029
608 ARTERIOSCLEROSIS 27 0.0029
609 GINGIVAL BLEEDING 39 0.0029
610 GASTRITIS 75 0.0028
611 ACUTE MYOCARDIAL INFARCTION 84 0.0028
612 SKIN DISORDER 95 0.0028
613 PULMONARY THROMBOSIS 31 0.0028
614 ERECTILE DYSFUNCTION 73 0.0028
615 COLD SWEAT 50 0.0028
616 EYE INFLAMMATION 27 0.0028
617 CLOSTRIDIUM DIFFICILE COLITIS 30 0.0028
618 SPLENOMEGALY 33 0.0028
619 SURGERY 165 0.0028
620 RASH PRURITIC 152 0.0028
621 BLOOD CREATININE INCREASED 183 0.0028
622 BLOOD URINE PRESENT 53 0.0028
623 DYSPNOEA 1571 0.0028
624 PRODUCT DOSE OMISSION ISSUE 815 0.0028
625 ASTHMA 313 0.0028
626 SKIN SWELLING 24 0.0028
627 MOOD SWINGS 88 0.0028
628 ABSCESS 44 0.0028
629 ELECTROLYTE IMBALANCE 32 0.0028
630 DECREASED IMMUNE RESPONSIVENESS 27 0.0027
631 LIVER DISORDER 122 0.0027
632 DISTURBANCE IN ATTENTION 147 0.0027
633 CRYING 99 0.0027
634 RASH MACULAR 95 0.0027
635 POST PROCEDURAL COMPLICATION 52 0.0027
636 LEUKOCYTOSIS 49 0.0027
637 DISORIENTATION 107 0.0027
638 HYPOXIA 95 0.0027
639 CONJUNCTIVITIS 50 0.0027
640 HYPOTHYROIDISM 86 0.0027
641 MALIGNANT MELANOMA 36 0.0027
642 THERAPY INTERRUPTED 192 0.0027
643 LYMPHADENOPATHY 95 0.0027
644 GASTRIC DISORDER 92 0.0027
645 DISABILITY 53 0.0027
646 FAECES DISCOLOURED 58 0.0027
647 HAIR DISORDER 22 0.0027
648 INCREASED APPETITE 51 0.0027
649 PRURITUS 1025 0.0027
650 HYPOMAGNESAEMIA 37 0.0027
651 APHASIA 80 0.0026
652 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 138 0.0026
653 DRY SKIN 352 0.0026
654 SPEECH DISORDER 138 0.0026
655 THERAPEUTIC RESPONSE SHORTENED 87 0.0026
656 DRUG INTOLERANCE 253 0.0026
657 INABILITY TO AFFORD MEDICATION 26 0.0026
658 PROSTATIC SPECIFIC ANTIGEN INCREASED 36 0.0026
659 INFLUENZA LIKE ILLNESS 215 0.0026
660 IRRITABILITY 157 0.0026
661 PARANOIA 45 0.0026
662 URINARY RETENTION 87 0.0026
663 CARDIO-RESPIRATORY ARREST 109 0.0026
664 ANAEMIA 497 0.0026
665 THERAPY NON-RESPONDER 117 0.0026
666 SMALL INTESTINAL OBSTRUCTION 32 0.0026
667 SUICIDAL IDEATION 238 0.0026
668 DEVICE RELATED INFECTION 40 0.0026
669 OSTEOMYELITIS 47 0.0026
670 OCULAR HYPERAEMIA 123 0.0026
671 FACIAL PARALYSIS 22 0.0026
672 MASS 36 0.0026
673 PALMAR-PLANTAR ERYTHRODYSAESTHESIA SYNDROME 60 0.0026
674 HAIR COLOUR CHANGES 32 0.0026
675 FEAR 69 0.0026
676 OESOPHAGITIS 28 0.0026
677 CHOKING 50 0.0026
678 DEAFNESS 67 0.0026
679 ABDOMINAL PAIN 596 0.0026
680 MENTAL IMPAIRMENT 62 0.0026
681 HYPERHIDROSIS 329 0.0026
682 PYELONEPHRITIS 22 0.0025
683 PSYCHOMOTOR HYPERACTIVITY 42 0.0025
684 MOUTH ULCERATION 53 0.0025
685 SEPSIS 280 0.0025
686 GENERALISED OEDEMA 31 0.0025
687 INJURY 176 0.0025
688 PRODUCT AVAILABILITY ISSUE 57 0.0025
689 MALNUTRITION 28 0.0025
690 RETINAL DETACHMENT 23 0.0025
691 MADAROSIS 29 0.0025
692 PRURITUS GENERALISED 54 0.0025
693 PULMONARY HYPERTENSION 52 0.0025
694 HYPERSENSITIVITY 462 0.0025
695 PULMONARY ARTERIAL HYPERTENSION 36 0.0025
696 HYPOTENSION 498 0.0025
697 CHROMATURIA 56 0.0025
698 EMPHYSEMA 25 0.0025
699 INTESTINAL OBSTRUCTION 93 0.0025
700 RASH 1073 0.0025
701 CONDITION AGGRAVATED 747 0.0025
702 MOOD ALTERED 67 0.0025
703 STAPHYLOCOCCAL INFECTION 81 0.0025
704 SYNCOPE 245 0.0024
705 GLAUCOMA 47 0.0024
706 PLEURAL EFFUSION 148 0.0024
707 RASH ERYTHEMATOUS 116 0.0024
708 SPUTUM DISCOLOURED 23 0.0024
709 PHOTOSENSITIVITY REACTION 40 0.0024
710 OPTIC NEURITIS 22 0.0024
711 HYPONATRAEMIA 136 0.0024
712 ORTHOSTATIC HYPOTENSION 42 0.0024
713 APATHY 35 0.0024
714 GENERAL PHYSICAL HEALTH DETERIORATION 276 0.0024
715 DYSGEUSIA 177 0.0024
716 PERICARDIAL EFFUSION 55 0.0024
717 GLYCOSYLATED HAEMOGLOBIN INCREASED 60 0.0024
718 MALAISE 1040 0.0024
719 PERSONALITY CHANGE 22 0.0024
720 PULMONARY OEDEMA 106 0.0024
721 LOSS OF CONSCIOUSNESS 303 0.0024
722 DRUG EFFECT LESS THAN EXPECTED 35 0.0024
723 DEMENTIA 66 0.0024
724 APPENDICITIS 22 0.0024
725 URTICARIA 393 0.0023
726 BREAST PAIN 25 0.0023
727 THERAPEUTIC RESPONSE DECREASED 142 0.0023
728 SWOLLEN TONGUE 73 0.0023
729 WITHDRAWAL SYNDROME 98 0.0023
730 CORONARY ARTERY OCCLUSION 32 0.0023
731 BLOOD TRIGLYCERIDES INCREASED 41 0.0023
732 VASCULITIS 27 0.0023
733 INTESTINAL PERFORATION 26 0.0023
734 TRANSIENT ISCHAEMIC ATTACK 78 0.0023
735 ADVERSE DRUG REACTION 207 0.0023
736 PYREXIA 797 0.0023
737 HYPOACUSIS 99 0.0023
738 RESTLESSNESS 84 0.0023
739 VOMITING 1076 0.0023
740 CYTOPENIA 28 0.0023
741 NIGHTMARE 79 0.0023
742 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 411 0.0023
743 ANOSMIA 33 0.0023
744 EMOTIONAL DISORDER 70 0.0023
745 CARDIAC FAILURE CONGESTIVE 182 0.0023
746 GASTROENTERITIS 33 0.0023
747 EUPHORIC MOOD 23 0.0022
748 COELIAC DISEASE 22 0.0022
749 TACHYCARDIA 199 0.0022
750 PARALYSIS 32 0.0022
751 ILL-DEFINED DISORDER 135 0.0022
752 MYELODYSPLASTIC SYNDROME 32 0.0022
753 ASCITES 65 0.0022
754 UPPER LIMB FRACTURE 44 0.0022
755 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 157 0.0022
756 BLINDNESS UNILATERAL 31 0.0022
757 TRANSFUSION 23 0.0022
758 METASTASES TO BONE 36 0.0022
759 THROAT TIGHTNESS 59 0.0022
760 SWELLING FACE 142 0.0022
761 LOCAL SWELLING 38 0.0022
762 BLOOD ALKALINE PHOSPHATASE INCREASED 54 0.0022
763 MUSCLE RIGIDITY 26 0.0022
764 ACTIVITIES OF DAILY LIVING IMPAIRED 43 0.0022
765 HYPERGLYCAEMIA 79 0.0022
766 SCAR 37 0.0022
767 HAEMOPTYSIS 60 0.0021
768 POST PROCEDURAL HAEMORRHAGE 25 0.0021
769 HALLUCINATION, AUDITORY 34 0.0021
770 SEIZURE 247 0.0021
771 ABNORMAL DREAMS 59 0.0021
772 COMPLICATION ASSOCIATED WITH DEVICE 31 0.0021
773 EJECTION FRACTION DECREASED 33 0.0021
774 HAEMATOMA 55 0.0021
775 DERMATITIS 44 0.0021
776 PHARYNGITIS 26 0.0021
777 BRADYCARDIA 111 0.0021
778 PROCEDURAL PAIN 58 0.0021
779 NEOPLASM 24 0.0021
780 HAEMATOCHEZIA 115 0.0021
781 INJECTION SITE BRUISING 166 0.0021
782 COLON CANCER 31 0.0021
783 NEOPLASM PROGRESSION 72 0.0021
784 ABASIA 51 0.0021
785 ABDOMINAL PAIN LOWER 52 0.0021
786 PRODUCT USE ISSUE 385 0.0020
787 INJECTION SITE PRURITUS 137 0.0020
788 BIPOLAR DISORDER 22 0.0020
789 AGITATION 147 0.0020
790 FLUID OVERLOAD 29 0.0020
791 DEEP VEIN THROMBOSIS 129 0.0020
792 ECONOMIC PROBLEM 30 0.0020
793 ANHEDONIA 52 0.0020
794 PRODUCT DOSE OMISSION 129 0.0020
795 PSORIASIS 257 0.0020
796 HYPERKALAEMIA 69 0.0020
797 INTERNATIONAL NORMALISED RATIO INCREASED 56 0.0020
798 BLINDNESS 80 0.0020
799 RASH PAPULAR 44 0.0020
800 CARDIAC DISORDER 183 0.0020
801 HEMIPARESIS 33 0.0019
802 UNDERDOSE 142 0.0019
803 NEUTROPHIL COUNT DECREASED 79 0.0019
804 GENERALISED TONIC-CLONIC SEIZURE 32 0.0019
805 BONE LOSS 29 0.0019
806 RENAL FAILURE 256 0.0019
807 COLITIS 73 0.0019
808 TREATMENT NONCOMPLIANCE 105 0.0019
809 DISEASE PROGRESSION 226 0.0019
810 PNEUMONITIS 52 0.0019
811 SKIN EXFOLIATION 161 0.0019
812 C-REACTIVE PROTEIN INCREASED 69 0.0019
813 INJECTION SITE RASH 58 0.0019
814 ACUTE KIDNEY INJURY 289 0.0019
815 INJECTION SITE URTICARIA 46 0.0019
816 DRUG EFFECT INCOMPLETE 68 0.0019
817 GASTROINTESTINAL HAEMORRHAGE 156 0.0019
818 INTENTIONAL PRODUCT MISUSE 163 0.0019
819 ARRHYTHMIA 88 0.0019
820 BACTERAEMIA 22 0.0019
821 PRODUCT TASTE ABNORMAL 25 0.0018
822 UPPER GASTROINTESTINAL HAEMORRHAGE 31 0.0018
823 ERYTHEMA 378 0.0018
824 MENTAL STATUS CHANGES 51 0.0018
825 PERITONITIS 38 0.0018
826 INJECTION SITE MASS 67 0.0018
827 BLOOD GLUCOSE DECREASED 87 0.0018
828 DYSMENORRHOEA 24 0.0018
829 LUNG INFECTION 28 0.0018
830 MENTAL DISORDER 78 0.0018
831 GASTRIC ULCER 34 0.0018
832 BLOOD GLUCOSE ABNORMAL 33 0.0018
833 RENAL IMPAIRMENT 150 0.0018
834 DRUG DOSE OMISSION 293 0.0018
835 PULMONARY EMBOLISM 168 0.0018
836 PNEUMOTHORAX 28 0.0018
837 PELVIC PAIN 32 0.0018
838 SUBDURAL HAEMATOMA 25 0.0017
839 HAEMORRHAGE INTRACRANIAL 26 0.0017
840 PRODUCT ADMINISTRATION ERROR 35 0.0017
841 HAEMORRHAGE 181 0.0017
842 DEVICE ISSUE 155 0.0017
843 DISEASE RECURRENCE 82 0.0017
844 SKIN REACTION 24 0.0017
845 MANIA 28 0.0017
846 BLOOD GLUCOSE INCREASED 320 0.0017
847 CORONARY ARTERY DISEASE 51 0.0017
848 PROTEINURIA 32 0.0017
849 ABNORMAL BEHAVIOUR 66 0.0017
850 BLOOD BILIRUBIN INCREASED 45 0.0017
851 ECZEMA 87 0.0017
852 EXPOSURE VIA SKIN CONTACT 43 0.0017
853 ASPARTATE AMINOTRANSFERASE INCREASED 88 0.0017
854 RECTAL HAEMORRHAGE 71 0.0017
855 TOXIC EPIDERMAL NECROLYSIS 25 0.0016
856 DIABETES MELLITUS INADEQUATE CONTROL 29 0.0016
857 ALANINE AMINOTRANSFERASE INCREASED 100 0.0016
858 UNRESPONSIVE TO STIMULI 42 0.0016
859 PRODUCT USE IN UNAPPROVED INDICATION 398 0.0016
860 INJECTION SITE SWELLING 123 0.0016
861 HYPERTHYROIDISM 23 0.0016
862 DIABETES MELLITUS 120 0.0016
863 HYPOGLYCAEMIA 76 0.0016
864 LIP SWELLING 52 0.0016
865 COAGULOPATHY 26 0.0016
866 PSYCHOTIC DISORDER 46 0.0016
867 HOSPITALISATION 239 0.0016
868 DIALYSIS 22 0.0015
869 OFF LABEL USE 1352 0.0015
870 SEPTIC SHOCK 67 0.0015
871 HYPOKALAEMIA 71 0.0015
872 GAMMA-GLUTAMYLTRANSFERASE INCREASED 34 0.0015
873 BLOOD LACTATE DEHYDROGENASE INCREASED 24 0.0015
874 DEVICE FAILURE 23 0.0015
875 RASH GENERALISED 39 0.0015
876 INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION 107 0.0015
877 DERMATITIS ATOPIC 79 0.0015
878 THROMBOCYTOPENIA 167 0.0015
879 PAIN OF SKIN 40 0.0015
880 FRACTURE 28 0.0015
881 RESPIRATORY FAILURE 107 0.0015
882 ADVERSE EVENT 133 0.0014
883 INJECTION SITE ERYTHEMA 179 0.0014
884 CEREBROVASCULAR ACCIDENT 244 0.0014
885 DRUG INTERACTION 225 0.0014
886 NEEDLE ISSUE 41 0.0014
887 MATERNAL EXPOSURE DURING PREGNANCY 125 0.0014
888 PALLOR 38 0.0014
889 NEUTROPENIA 188 0.0014
890 RENAL INJURY 41 0.0014
891 DEVICE DISLOCATION 60 0.0014
892 RESPIRATORY DISTRESS 38 0.0014
893 SEDATION 36 0.0014
894 APPLICATION SITE ERYTHEMA 36 0.0014
895 INJECTION SITE REACTION 94 0.0014
896 INJECTION SITE PAIN 416 0.0014
897 COLITIS ULCERATIVE 60 0.0013
898 LIVER FUNCTION TEST ABNORMAL 39 0.0013
899 DRUG-INDUCED LIVER INJURY 42 0.0013
900 EXPIRED PRODUCT ADMINISTERED 44 0.0013
901 DRUG INEFFECTIVE 1720 0.0013
902 TOOTH LOSS 27 0.0013
903 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 262 0.0013
904 ANGINA PECTORIS 37 0.0013
905 VAGINAL HAEMORRHAGE 56 0.0013
906 INJECTION SITE HAEMORRHAGE 103 0.0013
907 HYPOCALCAEMIA 24 0.0013
908 HAEMATURIA 43 0.0013
909 NERVOUS SYSTEM DISORDER 39 0.0012
910 SEROTONIN SYNDROME 24 0.0012
911 BONE DENSITY DECREASED 39 0.0012
912 PRODUCT PRESCRIBING ISSUE 27 0.0012
913 ACNE 93 0.0012
914 ENCEPHALOPATHY 30 0.0012
915 BLOOD CREATINE PHOSPHOKINASE INCREASED 35 0.0012
916 INCORRECT DOSE ADMINISTERED 277 0.0012
917 PANCREATITIS 64 0.0012
918 EPILEPSY 37 0.0012
919 PANCREATITIS ACUTE 27 0.0012
920 CEREBRAL HAEMORRHAGE 43 0.0012
921 PANCYTOPENIA 67 0.0012
922 HAEMATEMESIS 30 0.0012
923 CARDIOVASCULAR DISORDER 30 0.0012
924 MALIGNANT NEOPLASM PROGRESSION 121 0.0012
925 SKIN IRRITATION 54 0.0012
926 TARDIVE DYSKINESIA 33 0.0012
927 PREGNANCY 23 0.0011
928 CARDIAC FAILURE 92 0.0011
929 PRODUCT PHYSICAL ISSUE 23 0.0011
930 SKIN BURNING SENSATION 81 0.0011
931 MENORRHAGIA 22 0.0011
932 VISUAL ACUITY REDUCED 37 0.0011
933 MUCOSAL INFLAMMATION 29 0.0011
934 PRODUCT DISPENSING ERROR 24 0.0011
935 HEPATIC FAILURE 33 0.0011
936 NEOPLASM MALIGNANT 73 0.0011
937 CARDIAC ARREST 89 0.0011
938 PRODUCT QUALITY ISSUE 146 0.0011
939 PRODUCT PREPARATION ERROR 22 0.0011
940 MYOCARDIAL INFARCTION 186 0.0011
941 ACCIDENTAL OVERDOSE 39 0.0011
942 DEATH 899 0.0010
943 JAUNDICE 28 0.0010
944 INCORRECT PRODUCT ADMINISTRATION DURATION 22 0.0010
945 ANAPHYLACTIC REACTION 56 0.0010
946 BREAST CANCER 94 0.0010
947 APPLICATION SITE PAIN 22 0.0010
948 PREMATURE BABY 30 0.0010
949 DEPRESSED LEVEL OF CONSCIOUSNESS 39 0.0010
950 DRUG EFFECT DECREASED 53 0.0010
951 EMOTIONAL DISTRESS 117 0.0010
952 MULTIPLE ORGAN DYSFUNCTION SYNDROME 27 0.0010
953 EXPOSURE DURING PREGNANCY 59 0.0009
954 EXTRA DOSE ADMINISTERED 38 0.0009
955 AGGRESSION 46 0.0009
956 RHABDOMYOLYSIS 38 0.0009
957 TREATMENT FAILURE 75 0.0009
958 LEUKOPENIA 45 0.0009
959 DEVICE MALFUNCTION 63 0.0009
960 ELECTROCARDIOGRAM QT PROLONGED 31 0.0009
961 FEBRILE NEUTROPENIA 57 0.0009
962 MENSTRUATION IRREGULAR 23 0.0009
963 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 47 0.0009
964 DRUG ADMINISTRATION ERROR 26 0.0008
965 DEVICE BREAKAGE 33 0.0008
966 SUICIDE ATTEMPT 47 0.0008
967 DRUG WITHDRAWAL SYNDROME 68 0.0008
968 ACCIDENTAL EXPOSURE TO PRODUCT 79 0.0008
969 DEVICE LEAKAGE 33 0.0008
970 LUNG NEOPLASM MALIGNANT 30 0.0007
971 MEDICATION ERROR 40 0.0007
972 WRONG TECHNIQUE IN DRUG USAGE PROCESS 25 0.0007
973 METABOLIC ACIDOSIS 22 0.0007
974 INTERSTITIAL LUNG DISEASE 32 0.0007
975 ABORTION SPONTANEOUS 26 0.0006
976 DEVICE USE ERROR 22 0.0006
977 PRODUCT ADHESION ISSUE 22 0.0006
978 ANGIOEDEMA 27 0.0006
979 RENAL FAILURE ACUTE 25 0.0006
980 WRONG TECHNIQUE IN DEVICE USAGE PROCESS 27 0.0006
981 PRODUCT STORAGE ERROR 47 0.0005
982 DEVICE DIFFICULT TO USE 35 0.0005
983 OVERDOSE 113 0.0005
984 NO ADVERSE EVENT 94 0.0005
985 CONVULSION 28 0.0005
986 PROSTATE CANCER 39 0.0005
987 FOETAL EXPOSURE DURING PREGNANCY 38 0.0005
988 TOXICITY TO VARIOUS AGENTS 72 0.0004
989 INTENTIONAL OVERDOSE 26 0.0004
990 DRUG DEPENDENCE 33 0.0002